Advertisement
GKOS 外匯新聞
Glaukos Says FDA Oks NDA For Single Administration Per Eye Of IDose TR 75 Mcg
Pharmaceutical company Glaukos Corp. (GKOS) announced Thursday the U.S. Food and Drug Administration (FDA) approved its New Drug Application (NDA) for a single administration per eye of iDose TR (travoprost intracameral implant) 75 mcg.
RTTNews
|
624天前
